🇫🇷 Biosynex

ALBIO.PA
Healthcare · France · EUR · biosynex.com
Fundamentals
Gross Margin
-3.8%
Op. Margin
-4.9%
Net Margin
-61.1%
ROIC
-4.2%
Rev Growth
-5.9%
Valuation
Price
0.95 EUR
Day
+6.74%
52-Week Range
0.46 - 1.57
Market Cap
18M EUR
Fwd P/E
2.1x
EV/EBITDA
-
Div Yield
-
Annual income statement #

Biosynex annual revenue, operating income and net income in EUR, 2016 to 2025. Revenue was 95.2m in 2025.

Year Revenue (EUR) Operating income Net income Net margin
2025 95.2m -4.7m -58.2m -61.1%
2024 101.2m -21.1m -43.3m -42.8%
2023 93.0m -37.4m -36.9m -39.7%
2022 196.6m 38.9m 15.7m 8.0%
2021 382.5m 140.7m 104.0m 27.2%
2020 153.9m 45.7m 31.4m 20.4%
2019 34.2m 1.1m 1.1m 3.2%
2018 31.3m 371,759 542,894 1.7%
2017 30.6m 921,857 315,221 1.0%
2016 27.1m 801,191 -120,095 -0.4%
Financial Data #
Segment Breakdown #
Price & Multiples #
Peers #
SENZA.ST NN6.DE BCART.BR BOUL.ST IMMNOV.ST BMX.WA ALNOV.PA IDLDX.ST ALKLH.PA EEP.MC · Compare in Screener Dividends Bubble
Events #
Date Type Details Price Amount
See also: Healthcare in Screener Treemap - France Insider Buying - France France in Screener